2015 Press Releases

Keyword Search
 

October 20, 2015

Two Poster Presentations on Oral Peptides by Protagonist Therapeutics Accepted for the Upcoming 2015 Advances in IBD – Crohn’s & Colitis Foundation’s Clinical & Research Conference read more

September 23, 2015

Protagonist Therapeutics Receives SBIR Funding for Oral IL-23 Receptor Antagonists for Treatment of Inflammatory Bowel Diseases read more

September 10, 2015

Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer read more

July 16, 2015

Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development read more